Adage Capital Partners’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Sell |
96,000
-354,000
| -79% | -$7.1M | ﹤0.01% | 762 |
|
|
2025
Q1 | $8.86M | Sell |
450,000
-200,000
| -31% | -$3.94M | 0.02% | 609 |
|
|
2024
Q4 | $14.6M | Sell |
650,000
-150,000
| -19% | -$3.38M | 0.03% | 512 |
|
|
2024
Q3 | $20.4M | Sell |
800,000
-40,000
| -5% | -$1.02M | 0.04% | 443 |
|
|
2024
Q2 | $19.6M | Buy |
+840,000
| New | +$19.6M | 0.04% | 441 |
|